ATE361921T1 - Halothienoylcyclopropan-1-carbonsaeure-derivate - Google Patents
Halothienoylcyclopropan-1-carbonsaeure-derivateInfo
- Publication number
- ATE361921T1 ATE361921T1 AT03811772T AT03811772T ATE361921T1 AT E361921 T1 ATE361921 T1 AT E361921T1 AT 03811772 T AT03811772 T AT 03811772T AT 03811772 T AT03811772 T AT 03811772T AT E361921 T1 ATE361921 T1 AT E361921T1
- Authority
- AT
- Austria
- Prior art keywords
- branched
- linear
- alkyl
- halothienoylcyclopropane
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02026597A EP1424333A1 (de) | 2002-11-28 | 2002-11-28 | Halothenoyl-cyclopropan-1-carbonsäure-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361921T1 true ATE361921T1 (de) | 2007-06-15 |
Family
ID=32241303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03811772T ATE361921T1 (de) | 2002-11-28 | 2003-11-25 | Halothienoylcyclopropan-1-carbonsaeure-derivate |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060116329A1 (de) |
| EP (2) | EP1424333A1 (de) |
| JP (1) | JP4522864B2 (de) |
| AT (1) | ATE361921T1 (de) |
| AU (1) | AU2003296596B2 (de) |
| CA (1) | CA2507597A1 (de) |
| CY (1) | CY1106692T1 (de) |
| DE (1) | DE60313798T2 (de) |
| DK (1) | DK1565451T3 (de) |
| ES (1) | ES2286509T3 (de) |
| PT (1) | PT1565451E (de) |
| SI (1) | SI1565451T1 (de) |
| WO (1) | WO2004048361A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1475088A1 (de) * | 2003-05-05 | 2004-11-10 | Newron Pharmaceuticals S.p.A. | Kynurenine-3-hydroxylase Hemmer zur Behandlung von L-DOPA bedingten Bewegungsstörungen, Dyskinesien, Sucht, Schmerzen und Katarakt |
| GB2402940A (en) * | 2004-08-19 | 2004-12-22 | Pfizer Ltd | Biomarkers of inflammation and/or macrophage activation |
| JP2008535892A (ja) * | 2005-04-11 | 2008-09-04 | プロビオドルグ エージー | プロリルエンドペプチダーゼの阻害剤 |
| AR086992A1 (es) | 2011-06-20 | 2014-02-05 | Bayer Ip Gmbh | Tienilpiri(mi)dinilpirazoles |
| WO2013151707A1 (en) | 2012-04-05 | 2013-10-10 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2015047982A2 (en) * | 2013-09-26 | 2015-04-02 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| JP6449893B2 (ja) * | 2013-09-26 | 2019-01-09 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | キヌレニン−３−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
| GB201322512D0 (en) | 2013-12-19 | 2014-02-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201508857D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
| GB201508864D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1278435B (de) * | 1965-01-19 | 1968-09-26 | Merck Ag E | Verfahren zur Herstellung von 1, 2-disubstituierten Cyclopropanderivaten |
| US4022903A (en) * | 1975-06-05 | 1977-05-10 | Abbott Laboratories | α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides |
| US6274590B1 (en) * | 1993-01-15 | 2001-08-14 | G. D. Searle & Co. | Method of treating skin related conditions |
| JP4176150B2 (ja) * | 1996-10-30 | 2008-11-05 | 塩野義製薬株式会社 | グルタミン酸放出阻害剤および新規化合物 |
| GB9705031D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
-
2002
- 2002-11-28 EP EP02026597A patent/EP1424333A1/de not_active Withdrawn
-
2003
- 2003-11-25 US US10/536,307 patent/US20060116329A1/en not_active Abandoned
- 2003-11-25 AU AU2003296596A patent/AU2003296596B2/en not_active Ceased
- 2003-11-25 ES ES03811772T patent/ES2286509T3/es not_active Expired - Lifetime
- 2003-11-25 AT AT03811772T patent/ATE361921T1/de not_active IP Right Cessation
- 2003-11-25 WO PCT/EP2003/013244 patent/WO2004048361A1/en active IP Right Grant
- 2003-11-25 DE DE60313798T patent/DE60313798T2/de not_active Expired - Lifetime
- 2003-11-25 PT PT03811772T patent/PT1565451E/pt unknown
- 2003-11-25 SI SI200330828T patent/SI1565451T1/sl unknown
- 2003-11-25 CA CA002507597A patent/CA2507597A1/en not_active Abandoned
- 2003-11-25 EP EP03811772A patent/EP1565451B1/de not_active Expired - Lifetime
- 2003-11-25 DK DK03811772T patent/DK1565451T3/da active
- 2003-11-25 JP JP2004554463A patent/JP4522864B2/ja not_active Expired - Fee Related
-
2007
- 2007-07-02 CY CY20071100873T patent/CY1106692T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106692T1 (el) | 2012-05-23 |
| ES2286509T3 (es) | 2007-12-01 |
| CA2507597A1 (en) | 2004-06-10 |
| AU2003296596A1 (en) | 2004-06-18 |
| DE60313798D1 (en) | 2007-06-21 |
| EP1565451A1 (de) | 2005-08-24 |
| JP4522864B2 (ja) | 2010-08-11 |
| EP1565451B1 (de) | 2007-05-09 |
| AU2003296596B2 (en) | 2010-03-04 |
| US20060116329A1 (en) | 2006-06-01 |
| WO2004048361A1 (en) | 2004-06-10 |
| SI1565451T1 (sl) | 2007-08-31 |
| DE60313798T2 (de) | 2008-01-24 |
| DK1565451T3 (da) | 2007-09-10 |
| JP2006509753A (ja) | 2006-03-23 |
| EP1424333A1 (de) | 2004-06-02 |
| PT1565451E (pt) | 2007-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106692T1 (el) | Παραγωγα του αλοξενοϋλ-κυκλοπροπαν-1-καρβοξυλικου οξεος | |
| HN1997000027A (es) | Derivados de 6-fenil piridil - 2 amina | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| ATE389635T1 (de) | Pharmazeutisch wirksame piperidinderivate | |
| ES2193990T3 (es) | Derivados de purina. | |
| DK1076663T3 (da) | Funktionaliserede alkyl- og alkenylsidekædederivater af glycinamider som farnesyltransferaseinhibitorer | |
| DK1424330T3 (da) | Aktivator for peroxisom proliferator-responsiv receptor delta | |
| NO20061126L (no) | Aminopyroner og deres anvendelse som ATM-inhibitorer | |
| EP1490371A4 (de) | Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten | |
| NO20044063L (no) | Pyranoner anvendelige som ATM-inhibitorer | |
| FI20001593A0 (fi) | Comt-entsyymiä inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia | |
| DE60223904D1 (de) | Benzylaminanalogen | |
| DK0753511T3 (da) | 4-indol-1-ylsmørsyrederivater, deres fremstilling og deres anvendelse som inhibitorer af alfa 1-adrenerge receptorer og testosteron-5alfa-reduktaser | |
| DK1663122T3 (da) | Mundskyllesammensætninger indeholdende N-acyl-argininalkylestersalte | |
| ATE201402T1 (de) | Optisch aktive thiazolidinonderivate | |
| HUP0303760A2 (hu) | AZ NF-kB faktort gátló szubsztituált benzoesavszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| ES2190781T3 (es) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano. | |
| DK0819687T3 (da) | Benzothiophenforbindelser og anvendelser og formuleringer deraf | |
| DK0912573T3 (da) | Camptothecinderivater, som er isoleret fra Mappia foetida, og anvendelse deraf som syntoner for nye lægemidler og som terapeutiske midler | |
| DE60113808D1 (de) | Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat | |
| EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
| PE20030758A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion | |
| ATE284379T1 (de) | Aminderivate | |
| ATE259346T1 (de) | Benflumentolderivative und ihre verwendung gegen parasitäre protozoen und trematoden | |
| MY142362A (en) | Pharmaceutical composition for promoting angiogenesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1565451 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |